Standard Chem & Pharm CO., LTD. (1720.TW)
TWD 62.9
(-0.32%)
TWD 62.9
(-0.32%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 4.67 TWD | -27.71% |
| 2022 | 6.46 TWD | 63.13% |
| 2021 | 3.96 TWD | 35.15% |
| 2020 | 2.93 TWD | 38.86% |
| 2019 | 2.11 TWD | 0.96% |
| 2018 | 2.09 TWD | 2.96% |
| 2017 | 2.03 TWD | 6.84% |
| 2016 | 1.90 TWD | -2.56% |
| 2015 | 1.95 TWD | -6.7% |
| 2014 | 2.09 TWD | 20.81% |
| 2013 | 1.73 TWD | 5.49% |
| 2012 | 1.64 TWD | 11.56% |
| 2011 | 1.47 TWD | 16.67% |
| 2010 | 1.26 TWD | -28.41% |
| 2009 | 1.76 TWD | 7.32% |
| 2008 | 1.64 TWD | 1.86% |
| 2007 | 1.61 TWD | -17.44% |
| 2006 | 1.95 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.41 TWD | 56.67% |
| 2024 Q2 | 1.21 TWD | -14.18% |
| 2023 Q4 | 0.90 TWD | -28.0% |
| 2023 Q2 | 1.33 TWD | -19.88% |
| 2023 Q1 | 1.66 TWD | 69.39% |
| 2023 Q3 | 1.25 TWD | -6.02% |
| 2023 FY | - TWD | -27.71% |
| 2022 Q4 | 0.98 TWD | -51.96% |
| 2022 FY | - TWD | 63.13% |
| 2022 Q3 | 2.04 TWD | 10.27% |
| 2022 Q2 | 1.85 TWD | 41.22% |
| 2022 Q1 | 1.31 TWD | 11.02% |
| 2021 Q3 | 0.89 TWD | -4.3% |
| 2021 Q4 | 1.18 TWD | 32.58% |
| 2021 Q1 | 1.17 TWD | 30.0% |
| 2021 FY | - TWD | 35.15% |
| 2021 Q2 | 0.93 TWD | -20.51% |
| 2020 Q1 | 0.67 TWD | 21.82% |
| 2020 Q4 | 0.90 TWD | 40.63% |
| 2020 Q3 | 0.64 TWD | -12.33% |
| 2020 FY | - TWD | 38.86% |
| 2020 Q2 | 0.73 TWD | 8.96% |
| 2019 Q2 | 0.55 TWD | 37.5% |
| 2019 FY | - TWD | 0.96% |
| 2019 Q4 | 0.55 TWD | -9.84% |
| 2019 Q3 | 0.61 TWD | 10.91% |
| 2019 Q1 | 0.40 TWD | -24.53% |
| 2018 FY | - TWD | 2.96% |
| 2018 Q4 | 0.53 TWD | -19.7% |
| 2018 Q3 | 0.66 TWD | 20.0% |
| 2018 Q2 | 0.55 TWD | 57.14% |
| 2018 Q1 | 0.35 TWD | 25.0% |
| 2017 FY | - TWD | 6.84% |
| 2017 Q1 | 0.33 TWD | -25.0% |
| 2017 Q4 | 0.28 TWD | -67.82% |
| 2017 Q3 | 0.87 TWD | 55.36% |
| 2017 Q2 | 0.56 TWD | 69.7% |
| 2016 Q2 | 0.40 TWD | -11.11% |
| 2016 FY | - TWD | -2.56% |
| 2016 Q1 | 0.45 TWD | 4.65% |
| 2016 Q4 | 0.44 TWD | -27.87% |
| 2016 Q3 | 0.61 TWD | 52.5% |
| 2015 FY | - TWD | -6.7% |
| 2015 Q4 | 0.43 TWD | -18.87% |
| 2015 Q3 | 0.53 TWD | 26.19% |
| 2015 Q2 | 0.42 TWD | -27.59% |
| 2015 Q1 | 0.58 TWD | 41.46% |
| 2014 Q4 | 0.41 TWD | -25.45% |
| 2014 FY | - TWD | 20.81% |
| 2014 Q1 | 0.54 TWD | 184.21% |
| 2014 Q2 | 0.60 TWD | 11.11% |
| 2014 Q3 | 0.55 TWD | -8.33% |
| 2013 Q4 | 0.19 TWD | -40.63% |
| 2013 FY | - TWD | 5.49% |
| 2013 Q3 | 0.32 TWD | -40.74% |
| 2013 Q1 | 0.70 TWD | 84.21% |
| 2013 Q2 | 0.54 TWD | -22.86% |
| 2012 Q3 | 0.44 TWD | 62.96% |
| 2012 Q4 | 0.38 TWD | -13.64% |
| 2012 Q2 | 0.27 TWD | -48.08% |
| 2012 FY | - TWD | 11.56% |
| 2012 Q1 | 0.52 TWD | 20.93% |
| 2011 Q3 | 0.32 TWD | -15.79% |
| 2011 Q4 | 0.43 TWD | 34.37% |
| 2011 FY | - TWD | 16.67% |
| 2011 Q1 | 0.33 TWD | 230.0% |
| 2011 Q2 | 0.38 TWD | 15.15% |
| 2010 Q1 | 0.35 TWD | 0.0% |
| 2010 FY | - TWD | -28.41% |
| 2010 Q4 | 0.10 TWD | -72.97% |
| 2010 Q3 | 0.37 TWD | -15.91% |
| 2010 Q2 | 0.44 TWD | 25.71% |
| 2009 FY | - TWD | 7.32% |
| 2008 FY | - TWD | 1.86% |
| 2007 FY | - TWD | -17.44% |
| 2006 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Grape King Bio Ltd | 9.81 TWD | 52.396% |
| Maywufa Company Ltd. | 1.27 TWD | -267.717% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | -1197.222% |
| Lotus Pharmaceutical Co., Ltd. | 15.72 TWD | 70.293% |
| LIWANLI Innovation Co., Ltd. | 0.06 TWD | -7277.567% |
| YungShin Global Holding Corporation | 3.11 TWD | -50.161% |
| PhytoHealth Corporation | -0.24 TWD | 2045.833% |
| SCI Pharmtech, Inc. | 2.70 TWD | -72.963% |
| Formosa Laboratories, Inc. | 1.05 TWD | -344.762% |
| PharmaEssentia Corporation | -1.93 TWD | 341.969% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 84.536% |